On May 30, 2025, the Board of Directors of the Competition Authority, in the exercise of the powers conferred upon it by paragraph d) of paragraph 1 of article 19 of the Statutes, approved by Decree-Law no. 125/2014, of 18 August, decides to adopt a decision of non-opposition to the concentration operation, under the terms of paragraph b) of number 1 of article 50 of the Competition Law, since it is not susceptible to create significant impediments to effective competition in the national market or in a substantial part of it.

Portuguese Competition Authority Approves Merger Between Luz Saúde and C2 Capital Partners

The Portuguese competition authority, known as AdC, has issued a non-opposition decision regarding merger 91/2024, which involves Luz Saúde and C2 Capital Partners, along with GHB and Infrapetagi.

 On May 30, 2025, the Board of Directors of the AdC exercised its powers under the Competition Law to approve the merger. The decision was based on the assessment that the merger would not create significant impediments to effective competition in the national market or in a substantial part of it.

 This approval indicates that the AdC found no substantial concerns regarding market dominance or anti-competitive effects arising from the merger, allowing the involved parties to proceed with their plans without further regulatory hurdles.



The AdC issued a non-opposition decision to the merger 91/2024 - Luz Saúde*C2 Capital Partners/GHB*Infrapetagi*HL.
The AdC issued a non-opposition decision to the merger 91/2024 - Luz Saúde*C2 Capital Partners/GHB*Infrapetagi*HL.

Portuguese Competition Authority Approves Merger Between Luz Saúde and C2 Capital Partners

The Portuguese competition authority has approved the merger between Luz Saúde and C2 Capital Partners, determining it will not hinder competition in the market.